HBRM Stock Overview
Herborium Group, Inc., a botanical therapeutics company, develops, licenses, and markets proprietary, botanical based medicinal products to consumers and healthcare professionals.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Herborium Group, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0001 |
| 52 Week High | US$0.0002 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 3 Year Change | -92.86% |
| 5 Year Change | 0% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| HBRM | US Personal Products | US Market | |
|---|---|---|---|
| 7D | 0% | 3.2% | -3.2% |
| 1Y | 0% | -32.6% | 19.3% |
Return vs Industry: HBRM exceeded the US Personal Products industry which returned -32.6% over the past year.
Return vs Market: HBRM underperformed the US Market which returned 19.3% over the past year.
Price Volatility
| HBRM volatility | |
|---|---|
| HBRM Average Weekly Movement | 8,839.7% |
| Personal Products Industry Average Movement | 8.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: HBRM's share price has been volatile over the past 3 months.
Volatility Over Time: HBRM's weekly volatility has increased from 8448% to 8840% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | n/a | Agnes Olszewski | www.herborium.com |
Herborium Group, Inc., a botanical therapeutics company, develops, licenses, and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. It offers dermatology products, which include AcnEase, herbal medicinal product for enhancing conditions associated with hormonal acne and multiple symptoms of Rosacea; and AcnEase Skin Management System for the treatment of acne marks/scars. The company also provides sexual health and performance products that are non-prescriptive alternatives to selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, and surgical procedures, including hysterectomy.
Herborium Group, Inc. Fundamentals Summary
| HBRM fundamental statistics | |
|---|---|
| Market cap | US$1.09m |
| Earnings (TTM) | US$68.20k |
| Revenue (TTM) | US$259.10k |
0.0x
P/E Ratio0.0x
P/S RatioIs HBRM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HBRM income statement (TTM) | |
|---|---|
| Revenue | US$259.10k |
| Cost of Revenue | US$90.70k |
| Gross Profit | US$168.40k |
| Other Expenses | US$100.20k |
| Earnings | US$68.20k |
Last Reported Earnings
Aug 31, 2012
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did HBRM perform over the long term?
See historical performance and comparison